Meet the Team
Dr. Neil J. Shah, MD
Co-Host & Toxicity Management Expert
Dr. Matthew Dallos, MD
Co-Host & Clinical Innovator
Empowering healthcare teams to master the use of modern cancer therapies, thereby extending patients' time on treatment while improving their quality of life.
OncTox Academy is your trusted partner in navigating the rapidly evolving oncology treatment landscape. We educate and empower healthcare teams with practical, evidence-based strategies that support the safe and effective use of modern cancer therapies—helping patients remain on treatment longer while improving outcomes and quality of life.
An exclusive, multidisciplinary gathering advancing the safe and effective use of next-generation oncology therapies. Practical, team-based discussions focused on smarter, safer toxicity management.
Dr. Neil J. Shah is a leading academic medical oncologist whose pioneering work in real-world toxicity management is transforming how clinicians approach next-generation cancer therapies. His research excellence spans modern oncology treatment-related adverse events, data-driven oncology solutions, and clinical outcomes optimization— contributions that have shaped practice standards through publications in premier medical journals.
As a dedicated educator and mentor, Dr. Shah has guided numerous trainees to success, fostering the next generation of oncology leaders. His unique ability to translate complex clinical research into real-world practice sets him apart in the field.
Through the OncTox Academy Podcast, Dr. Shah delivers expertly crafted, multidisciplinary education that empowers oncology teams to master the art of recognizing, preventing, and managing treatment-related toxicities. His patient-centered approach and evidence-based methodology directly translate to extended treatment duration and enhanced quality of life for patients—making him an indispensable voice in the oncology community.
Dr. Matthew Dallos is an academic oncologist at the forefront of modern cancer treatment innovation. As a distinguished clinical and translational researcher, he pioneers cutting-edge clinical trials that are reshaping the landscape of immune and targeted therapies across multiple cancer types.
His groundbreaking work has earned him prestigious recognition, including multiple grants and young investigator awards— testament to his commitment to advancing patient care through scientific excellence.
On the OncTox Academy Podcast, Dr. Dallos transforms complex therapeutic concepts into actionable insights, bridging the critical knowledge gap between academic breakthroughs and community practice. His expertise in next-generation cancer therapies and sophisticated toxicity management strategies empowers healthcare professionals worldwide to deliver truly smarter, safer cancer care.